137 related articles for article (PubMed ID: 37199498)
21. Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.
Huang FY; Wong DK; Tsui VW; Seto WK; Mak LY; Cheung TT; Lai KK; Yuen MF
BMC Cancer; 2019 Aug; 19(1):789. PubMed ID: 31395065
[TBL] [Abstract][Full Text] [Related]
22. Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas.
Amaddeo G; Cao Q; Ladeiro Y; Imbeaud S; Nault JC; Jaoui D; Gaston Mathe Y; Laurent C; Laurent A; Bioulac-Sage P; Calderaro J; Zucman-Rossi J
Gut; 2015 May; 64(5):820-9. PubMed ID: 25021421
[TBL] [Abstract][Full Text] [Related]
23. The Association Between Hepatitis B Virus Mutations and the Risk of Liver Disease and Hepatocellular Carcinoma.
Akrami H; Monjezi MR; Ilbeigi S; Amiri F; Fattahi MR
Curr Mol Med; 2022; 22(6):514-523. PubMed ID: 34397330
[TBL] [Abstract][Full Text] [Related]
24. Investigating genetic characteristics of hepatitis B virus-associated and -non-associated hepatocellular carcinoma.
Fu XH; Li M; Lou HB; Huang MS; Liu CL
Genet Res (Camb); 2016 Nov; 98():e14. PubMed ID: 27834158
[TBL] [Abstract][Full Text] [Related]
25. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
26. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
[TBL] [Abstract][Full Text] [Related]
27. Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.
Li W; Chen G; Yu X; Shi Y; Peng M; Wei J
Int J Clin Exp Pathol; 2013; 6(6):1076-85. PubMed ID: 23696925
[TBL] [Abstract][Full Text] [Related]
28. Identification of Warning Transition Points from Hepatitis B to Hepatocellular Carcinoma Based on Mutation Accumulation for the Early Diagnosis and Potential Drug Treatment of HBV-HCC.
Xu F; Meng Q; Wu F; Wang Y; Yang W; Tong Y; Liu L; Chen X
Oxid Med Cell Longev; 2022; 2022():3472179. PubMed ID: 36105485
[TBL] [Abstract][Full Text] [Related]
29. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
30. Imaging Features on Contrast-Enhanced Ultrasound and Clinical Characteristics of Hepatitis B Virus-Related Combined Hepatocellular-Cholangiocarcinoma: Comparison with Hepatitis B Virus-Related Hepatocellular Carcinoma.
Ye J; Xie X; Liu B; Zhang X; Wang W; Huang X; Lu M; Huang G
Ultrasound Med Biol; 2017 Nov; 43(11):2530-2536. PubMed ID: 28847498
[TBL] [Abstract][Full Text] [Related]
31. Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.
Yang X; Guo X; Chen Y; Chen G; Ma Y; Huang K; Zhang Y; Zhao Q; Winkler CA; An P; Lyu J
Oncotarget; 2016 May; 7(19):27838-47. PubMed ID: 27056898
[TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China.
Yuan JM; Ambinder A; Fan Y; Gao YT; Yu MC; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):590-4. PubMed ID: 19190166
[TBL] [Abstract][Full Text] [Related]
33. Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study.
Yuen MF; Tanaka Y; Mizokami M; Yuen JC; Wong DK; Yuan HJ; Sum SM; Chan AO; Wong BC; Lai CL
Carcinogenesis; 2004 Sep; 25(9):1593-8. PubMed ID: 15090469
[TBL] [Abstract][Full Text] [Related]
34. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
35. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China.
Qu LS; Liu JX; Liu TT; Shen XZ; Chen TY; Ni ZP; Lu CH
PLoS One; 2014; 9(5):e98257. PubMed ID: 24849936
[TBL] [Abstract][Full Text] [Related]
36. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
[TBL] [Abstract][Full Text] [Related]
37. Genotypes and Hot Spot Mutations of Hepatitis B Virus in Northwest Chinese Population and Its Correlation with Diseases Progression.
Wang W; Shu Y; Bao H; Zhao W; Wang W; Wang Q; Lei X; Cui D; Yan Z
Biomed Res Int; 2019; 2019():3890962. PubMed ID: 31886206
[TBL] [Abstract][Full Text] [Related]
38. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.
Jiang D; Deng J; Dong C; Ma X; Xiao Q; Zhou B; Yang C; Wei L; Conran C; Zheng SL; Ng IO; Yu L; Xu J; Sham PC; Qi X; Hou J; Ji Y; Cao G; Li M
BMC Cancer; 2020 May; 20(1):403. PubMed ID: 32393195
[TBL] [Abstract][Full Text] [Related]
39. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma.
Han J; Chen C; Wang C; Qin N; Huang M; Ma Z; Zhu M; Dai J; Jiang Y; Ma H; Jin G; Shen H; Hu Z
Liver Int; 2020 Sep; 40(9):2117-2127. PubMed ID: 32574393
[TBL] [Abstract][Full Text] [Related]
40. Clinical relevance and public health significance of hepatitis B virus genomic variations.
Cao GW
World J Gastroenterol; 2009 Dec; 15(46):5761-9. PubMed ID: 19998495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]